Experience on endoscopic retrograde cholangiopancreatography at tertiary referral center in Thailand: Risks and complications

Journal of the Medical Association of Thailand

Volumn 88, Issue 2, 2005, Pages 238-246

  Pungpapong, Surakit ^a   Kongkam, Pradermchai ^b   Rerknimitr, Rungsun ^b,c   Kullavanijaya, Pinit ^b  

^a MAYO CLINIC   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Complication; ERCP; Risk factor

Indexed keywords

ADOLESCENT; ADULT; AGED; BILE DUCT CARCINOMA; BILE DUCT DILATATION; CHOLANGITIS; DIGESTIVE SYSTEM HEMORRHAGE; DIGESTIVE SYSTEM PERFORATION; DUODENUM DIVERTICULUM; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ODDI SPHINCTER; PANCREAS DUCT; PANCREAS DUCT STENT; PANCREATITIS; REVIEW; RISK FACTOR; SPHINCTEROTOMY; STENT; TERTIARY REFERRAL CENTER; THAILAND; UNIVERSITY HOSPITAL; VATER PAPILLA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; THAILAND;

EID: 20444463493     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-18.
2. Classen M, Demling L. Endoskopische Sphinkterotomic der Papilla Vateri und Steinextraktion aus dem Ductus choledochus. Dtsch Med Wochenschr 1974; 00: 496-7.
3. Kawai K, Akasaka Y, Murakami K, Tada M, Kohli Y. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc 1974; 20: 148-51.
4. Cohen S, Bacon BR, Berlin JA, Fleischer D, Hecht GA, Loehrer PJ, et al. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002; 56: 803-9.
5. Strasberg SM, Soper NJ. Management of choledocholithiasis in the laparoscopic era. Gastroenterology 1995; 109: 320-2.
6. Cotton PB, Chung SC, Davis WZ, Gibson RM, Ransohoff DF, Strasberg SM. Issues in cholecystectomy and management of duct stones. Am J Gastroenterol 1994; 89(Suppl): S169-76.
7. Ponsky JL. Alternative methods in the management of bile duct stones. Surg Clin North Am 1992; 72: 1099-107.
8. Aliperti G, Edmundowicz SA, Soper NJ, Ashley SW. Combined endoscopic sphincterotomy and laparoscopic cholecystectomy in patients with choledocholithiasis and cholecystolithiasis. Ann Intern Med 1991; 115: 783-5.
9. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991; 101: 1068-75.
10. Roberts-Thompson IC, Toouli J. Is endoscopic sphincterotomy for disabling biliary-type pain after cholecystectomy effective? Gastrointest Endosc 1985; 31: 370-3.
11. Geenan JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. N Engl J Med 1989; 320: 82-7.
12. Thatcher BS, Sivak MV, Tedesco FJ, Vennes JA, Hutton SW, Achkar EA. Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi. Gastrointest Endosc 1987; 33: 91-5.
13. Neoptolemos JP, Bailey IS, Carr-Locke DL. Sphincter of Oddi dysfunction: results of treatment by endoscopic sphincterotomy. Br J Surg 1988; 75: 454-9.
14. Sherman S, Hawes R, Earle D, Baute P, Bucksot L, Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? Randomized prospective study. Gastrointest Endosc 1994; 40 (Suppl): P124. abstract.
15. Cotton PB. Precut papillotomy - a risky technique for experts only. Gastrointest Endosc 1989; 35: 578-9.
16. Shakoor T, Geenan JE. Pre-cut papillotomy. Gastrointest Endosc 1992; 38: 623-7.
17. Huibregtse K, Katon RM, Tytgat GNJ. Precut papillotomy via fine needle-knife papillotome: a safe and effective technique. Gastrointest Endosc 1986; 32: 403-5.
18. Kim MH, Lee SK, Lee MH, Myung SJ, Yoo BM, Seo DW, Min YI. Endoscopic retrograde cholangiopancreatography and needle-knife sphincterotomy in patients with Billroth II gastrectomy: a comparative study of the forward-viewing endoscope and the side-viewing duodenoscope. Endoscopy. 1997; 29: 82-5.
19. Huibregtse K. Complications of endoscopic sphincterotomy and their prevention. N Engl J Med 1996; 335: 961-3.
20. Escourrou J, Delvaux M, Biscail L, Fregevu J, Frexinos J, Ribet A. Clinical results of endoscopic sphincterotomy: complication of two activity periods in the same endoscopic units. Gastrointest Endosc 1990; 36: 205-6.
21. Jowell PS, Baillie J, Branch MS, Affronti J, Phillips-Bute B, Browning CL. Quantitative assessment of procedural competence: a prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern Med 1996; 125: 983-9.
22. Seifert E, Schulte F, Chalybaus C. Quo vadis endoskopische sphincterotomie? Gastroenterol 1989; 27: 77-92.
23. Kowalski T, Kanchana T, Pungpapong S. Perceptions of gastroenterology fellows regarding ERCP competency and training. Gastrointest Endosc 2003; 58: 345-9.
24. Boender J, Nix GA, de Ridder MA, van Blankenstein M, Schutte HE, Dees J, et al. Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate. Endoscopy 1994; 26: 209-16.
25. Cotton PB, Lehman G, Vennes JA, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-93.
26. Sherman S, Lehman GA. Complications of endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy: management and prevention. In: Barkin JS, O'Phelan CA, eds. Advanced therapeutic endoscopy. New York: Raven Press, 1990: 201-10.
27. Ostroff JW, Shapiro HA. Complications of endoscopic sphincterotomy. In: Jacobson IM, ed. ERCP: diagnostic and therapeutic applications. New York: Elsevier Science, 1989: 61-73.
28. Neoptolemos JP, Shaw DE, Carr-Locke DL. A multivariate analysis of preoperative risk factors in patients with common bile duct stones. Ann Surg 1989; 209: 157-61.
29. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991; 6: 305-67.
30. [Erratum, Pancreas 1992; 7: 402.]
31. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994; 89: 327-33.
32. Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc 1990; 36: 462-6.
33. Nebel OT, Silvis SE, Rogers G, Sugawa C, Mandelstam P. Complications associated with endoscopic reteroscopic cholangiopancreatography: results of the 1974 ASGE survey. Gastrointest Endosc 1975; 22: 34-6.
34. De Palma GD, Catanzano C. Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999; 94: 982-5.
35. LaFerla G, Gordon S, Archibald M, Murray WR. Hyperamylasaemia and acute pancreatitis following retrograde cholangiography. Pancreas 1985; 1: 160-3.
36. Rabenstein T, Hahn EG. Post-ERCP pancreatitis: new momentum. Endoscopy 2002; 34: 325-9.
37. Freeman ML. Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents? Gastroenterol 2003; 124: 1977-80.
38. Poon RTP, Fan ST. Antisecretory agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results. J Pancreas 2003; 4: 33-40.
39. Testoni PA. Preventing post-ERCP pancreatitis: where are we? J Pancreas 2003; 4: 22-32.
40. Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, De Maio G. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. J Pancreas 2003; 4: 41-48.
41. Romangnulo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiography: a metaanalysis of test performance in suspected biliary disease. Ann Intern Med 2003; 139: 547-57.
42. Poon RTP, Yeung C, Chung-Mau L, Wai-Kei Y, Chi-Leung L, Fan S. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999; 49: 593-8.
43. Persson B, Slezak P, Efendic S, Haggmark A. Can somatostatin prevent injection pancreatitis after ERCP? Hepatogastroenterology 1992; 39: 259-61.
44. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V, and The gabexate in digestive endoscopy - Italian group. Gabexate for the prevention, of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996; 335: 919-23.
45. Sherman S, Earle D, Bucksot L, Esber E, Hawes R, Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy induced pancreatitis? Am J Gastroenterol 1995; 90: 1614.
46. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-24.
47. Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenan JE. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003; 57: 291-4.
48. Rerknimitr R, Kullavanijaya P. Endoscopic management of cholangiocarcinoma. J Med Assoc Thai 2001; 84; S452-5.
49. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991; 101: 1374-81.